About Parataxis Capital
Parataxis Capital is a company based in New York (United States) founded in 2019. It operates as a Professional Services and FinTech. Parataxis Capital has completed 2 acquisitions, including Bridge Biotherapeutics and Strix Leviathan. Parataxis Capital offers products and services including Digital Asset Investment Advisory.
- Headquarter New York, United States
-
Sectors
Financial Services
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
Bridge Biotherapeutics
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Parataxis Capital
Parataxis Capital offers a comprehensive portfolio of products and services, including Digital Asset Investment Advisory.
Investment advisory services are provided for digital assets.
People of Parataxis Capital
Unlock access to complete
Unlock access to complete
Funding Insights of Parataxis Capital
Detailed funding history for Parataxis Capital
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Parataxis Capital
Parataxis Capital has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Bridge Biotherapeutics and Strix Leviathan.
Investment portfolio details for Parataxis Capital
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Crypto investment platform for institutional investors
|
Locked | Locked | 2018 | Locked | |
|
Small molecule therapeutics are developed for treating various diseases.
|
Locked | Locked | 2015 | Locked |
Complete acquisition details for Parataxis Capital
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Parataxis Capital
Detailed financials for Parataxis Capital
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Parataxis Capital Comparisons
Peer comparison for Parataxis Capital
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Parataxis Capital
Detailed competitors of Parataxis Capital
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Parataxis Capital
Complete news archive for Parataxis Capital
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Parataxis Capital
Parataxis Capital was founded in 2019.
Parataxis Capital is headquartered in New York, United States. It is registered at New York, New York, United States.
Parataxis Capital Management LLC is engaged in providing multi-strategy investment advisory services within the digital asset sector. The firm is composed of a team with extensive experience in traditional financial markets and digital assets, emphasizing disciplined risk management. Services are tailored for institutional allocators, family offices, and high-net-worth individuals, aiming to deliver uncorrelated and risk-managed exposure to the digital asset ecosystem. The approach is supported by leveraging market inefficiencies and employing diverse investment strategies across market cycles.
Parataxis Capital offers Digital Asset Investment Advisory.
Parataxis Capital has made 2 acquisitions, including Bridge Biotherapeutics, and Strix Leviathan.